Nightly News
| May 26, 2013
FDA gives thumbs down to popular asthma drugs
Dec. 11: The FDA Thursday recommended that two long-acting asthma drugs, Foradil and Serevent, be taken off the market, but suggested that Advair and Symbicort could continue to be sold by prescription. NBC's Robert Bazell reports.